Pembrolizumab-induced acute exacerbation of hepatitis D.

Fichtl, Anna; Beck, Annika; Seufferlein, Thomas; Zizer, Eugen

Fichtl, Anna; Beck, Annika; Seufferlein, Thomas; Zizer, Eugen.

Affiliation

Fichtl A; Internal Medicine I, University Hospital Ulm, Ulm, Germany.
Beck A; Institute of Pathology, University Hospital Ulm, Ulm, Germany.
Seufferlein T; Internal Medicine I, University Hospital Ulm, Ulm, Germany.
Zizer E; Internal Medicine I, University Hospital Ulm, Ulm, Germany.

Z Gastroenterol ; 61(7): 832-835, 2023 Jul.

Article in En | MEDLINE | ID: mdl-36377139

Subject(s)

Carcinoma, Non-Small-Cell Lung; Hepatitis B, Chronic; Hepatitis D; Lung Neoplasms; Male; Humans; Middle Aged; Carcinoma, Non-Small-Cell Lung/diagnosis; Carcinoma, Non-Small-Cell Lung/drug therapy; Hepatitis Delta Virus/genetics; Lung Neoplasms/diagnosis; Lung Neoplasms/drug therapy; Antiviral Agents/adverse effects; Tenofovir/adverse effects; Hepatitis D/diagnosis; Hepatitis D/drug therapy; Interferon-alpha/adverse effects; Hepatitis B, Chronic/drug therapy; RNA/therapeutic use

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepatitis D / Carcinoma, Non-Small-Cell Lung / Hepatitis B, Chronic / Lung Neoplasms Type of study: Prognostic_studies Limits: Humans / Male / Middle aged Language: En Journal: Z Gastroenterol Year: 2023 Type: Article Affiliation country: Germany

Fulltext

XML

PubMed Links

Search on Google